In response to a devastating start to the new year with wildfires continuing to advance through the greater Los Angeles area, Pet King Brands, leader of the veterinarian-recommended ZYMOX® and ...

Food - Microbial contamination ? SalmonellaDistribution: Ontario See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA) ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

In this fundamental study, the authors describe a new data processing pipeline that can be used to discover causal interactions from time-lapse imaging data. The utility of this pipeline was ...

Halozyme has separately combined recombinant human hyaluronidase – an enzyme found to have properties helpful to the administration of drugs in patients – with two existing medicinal products: ...

One or more of the following drugs will also be offered depending on the genetic profile of the tumour: futibatinib, ivosidenib, zanidatamab, trastuzumab, neratinib, encorafenib and binimetinib.

Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth factor receptor 2 (HER2)-positive breast ...

An updated long-term analysis of the Phase III KATHERINE trial confirms that adjuvant treatment with Kadcyla (trastuzumab emtansine) significantly improves overall survival and long-term invasive ...

MAINZ, Germany, January 14, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today will present its 2025 strategic priorities and progress on the Company ...

Pure CBD is good for anyone looking to avoid THC entirely!” — Christy Snyder With countless CBD brands on the market today, you may be wondering where to begin. We did the research so you can ...

have led to the development of successful drugs like Enhertu (trastuzumab deruxtecan), a HER2-directed ADC, and Datroway (datopotamab deruxtecan), a TROP-2-directed ADC. Yesterday [13 January ...